eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking »

Document ID: 
Document Type: 
Agency: 
Topics: No Topics associated with this document
View Document:  View as format xml

Details Information

Document Subtype: Public Comment
Received Date: May 10 2006, at 03:03 PM Eastern Daylight Time
Page Count: 7

Attachments:

Comment submitted by Stephen A. Campbell, Senior Vice President, Regulatory Affairs, Amphastar Pharmaceuticals, Inc. for Armstrong Pharmaceuticals, Inc.

View Attachment: View as format pdf

Comments

Total: 0
No comments posted.

Related Documents

Total: 0
No documents available.